Ferric reducing ability of tears in healthy subjectsDiurnal variation and dependence on defined demographic data

Current Eye Research

Volumn 34, Issue 5, 2009, Pages 333-339

  Kowalski, Michal ^a   Bielecka Kowalska, Anna ^a   Bielecka Roszkiewicz, Katarzyna ^a   Dziankowska Zaborszczyk, Elzbieta ^b   De Graft Johnson, Jeffrey ^b   Szemraj, Janusz ^b   Zwolinska, Anna ^b   Nowak, Dariusz ^b  

^a Medical Centre Sal Med   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Antioxidant activity; Circadian rhythm; Iron reduction; Ocular antioxidant defense; Tear ferric reducing ability

Indexed keywords

FERRIC ION; ANTIOXIDANT;

ADULT; AGE; AGED; AROUSAL; ARTICLE; BODY MASS; CHILD; CIRCADIAN RHYTHM; CONTROLLED STUDY; EVALUATION; FEMALE; FERRIC REDUCING ABILITY OF TEAR; GENDER; HUMAN; LABORATORY TEST; LACRIMAL FLUID; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; ADOLESCENT; AGING; CHEMISTRY; COMPARATIVE STUDY; EYE; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION; PLASMA; REFERENCE VALUE;

ADOLESCENT; ADULT; AGED; AGING; ANTIOXIDANTS; CHILD; CIRCADIAN RHYTHM; EYE; FEMALE; FERRIC COMPOUNDS; HUMANS; MALE; MIDDLE AGED; OXIDATION-REDUCTION; PLASMA; REFERENCE VALUES; TEARS; YOUNG ADULT;

EID: 67649666935     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.1080/02713680902815268     Document Type: Article

References (32)

1. Meyers SM, Ostrovsky MA, Bonner RF. A model of spectral filtering to reduce photochemical damage in age-related macular degeneration. Trans Am Ophthalmol Soc 2004;102:83-95.
2. Cejková J, Stípek S, Crkovská J, Ardan T, Pláteník J, Cejka C, Midelfart A. UV rays, the prooxidant/antioxidant imbalance in the cornea and oxidative eye damage. Physiol Res 2004;53:1-10.
3. Pokhrel AK, Smith KR, KhalakdinaA,DeujaA,BatesMN. Case-control study of indoor cooking smoke exposure and cataract in Nepal and India. Int J Epidemiol 2005;34:702-708.
4. Winkler BS, Boulton ME, Gottsch JD, Sternberg P. Oxidative damage and age-related macular degeneration. Mol Vis 1999;5:32.
5. Vinson JA. Oxidative stress in cataracts. Pathophysiology 2006;13:151-162.
6. Behndig A, Svensson B, Marklund SL, Karlsson K. Superoxide dismutase isoenzymes in the human eye. Invest Ophthalmol Vis Sci 1998;39:471-475.
7. Akerström B, Maghzal GJ, Winterbourn CC, Kettle AJ. The lipocalin alpha1-microglobulin has radical scavenging activity. J Biol Chem 2007;282:31493-31503.
8. Zhou L, Beuerman RW, Foo Y, Liu S, Ang LP, Tan DT. Characterisation of human tear proteins using high-resolution mass spectrometry. Ann Acad Med Singapore 2006;35:400-407.
9. Choy CK, Cho P, Chung WY, Benzie IF. Water-soluble antioxidants in human tears: Effect of the collection method. Invest Ophthalmol Vis Sci 2001;42:3130-3134.
10. Choy C, Benzie I, Cho P. Antioxidantsin tears and plasma: Interrelationships and effect of vitamin C supplementation. Curr Eye Res 2003;27:55-60.
11. Gogia R, Richer SP, Rose RC. Tear fluid content of electrochem-ically active components including water soluble antioxidants. Curr Eye Res 1998;17:257-263.
12. Bando M, Oka M, Kawai K, Obazawa H, Takehana M. NADH photo-oxidation is enhanced by a partially purified lambda-crystallin fraction from rabbit lens. Mol Vis 2007;13:1722-1729.
13. Choy CK, Benzie IF, Cho P. Ascorbic acid concentration and total antioxidant activity of human tear fluid measured using the FRASC assay. Invest Ophthalmol Vis Sci 2000;41:3293-3298.
14. Benzie IFF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": The FRAP assay. Anal Biochem 1996;239:70-76.
15. Pearl A, Carracedo G, Acosta MC, Gallar J, Pintor J. Increased levels of diadenosine polyphosphates in dry eye. Invest Ophthalmol Vis Sci 2006;47:4053-4058.
16. Callender M, Morrison PE. A quantitative study of human tear proteins before and after adaptation to non-flexible contact lenses. Am J Optom Physiol Opt 1974;51:939-945.
17. de Graft-Johnson J, Kolodziejczyk K, Krol M, Nowak P, Krol B, Nowak D. Ferric-reducing ability power of selected plant polyphenols and their metabolites: Implications for clinical studies on the antioxidant effects of fruits and vegetable consumption. Basic Clin Pharmacol Toxicol 2007;100:345-352.
18. Chrzczanowicz J, Gawron A, Zwolinska A, de Graft-Johnson J, Krajewski W, Krol M, Markowski J, Kostka T, Nowak D. Simple method for determining human serum 2,2-diphenyl-1-picryl-hydrazyl (DPPH) radical scavenging activity - possible application in clinical studies on dietary antioxidants. Clin Chem Lab Med 2008;46:342-349.
19. Diaz-Flores M, Baiza-Gutman LA, Pedron NN, Hicks JJ. Uterine glutathione reductase activity: Modulation by estrogens and progesterone. Life Sci1999;65:2481-2488.
20. Gomez-Zubeldia MA, Hernandez R, Viguera J, Arbues JJ, Apari-cio A, Millan JC. Effect of bilateral ovariectomy and ovarian steroid hormones on the antioxidant systems and plasma mal-ondialdehyde levels in wistar rats. Endoc Res 2000;26:97-107.
21. Giangiacomo A, Olesen PR, Ortwerth BJ. Ascorbic acid and glucose oxidation by ultraviolet A-generated oxygen free radicals. Invest Ophthalmol Vis Sci 1996;37:1549-1556.
22. Gilbard JP, Cohen GR, Baum J. Decreased tear osmolarity and absence of the inferior marginal tear strip after sleep. Cornea 1992;11:231-233.
23. Blanco RA, Ziegler TR, Carlson BA, Cheng PY, Park Y, Cotsonis GA, Accardi CJ, Jones DP. Diurnal variation in glutathione and cysteine redox states in human plasma. Am J Clin Nutr 2007;86:1016-1023.
24. Suliman ME, Anderstam B, Lindholm B, Bergstrom J. Total, free, and protein-bound sulphur amino acids in uraemic patients. Nephrol Dial Transplant 1997;12:2332-2338.
25. Castilla P, Echarri R, Davalos A, Cerrato F, Ortega H, Teruel JL, Lucas MF, Gómez-Coronado D, Ortuño J, Lasunción MA. Concentrated red grape juice exerts antioxidant, hypolipidemic, and anti-inflammatory effects in both hemodialysis patients and healthy subjects. Am J Clin Nutr 2006;84:252-262.
26. Lenton KJ, Sané AT, Therriault H, Cantin AM, Payette H, Wagner JR. Vitamin C augments lymphocyte glutathione in subjects with ascorbate deficiency. Am J Clin Nutr 2003;77:189-195.
27. Rutten EP, Engelen MP, Wouters EF, Schols AM, Deutz NE. Metabolic effects of glutamine and glutamate ingestion in healthy subjects and in persons with chronic obstructive pulmonary disease. Am J Clin Nutr 2006;83:115-123.
28. Verlaan M, Roelofs HM, van-Schaik A, Wanten GJ, Jansen JB, Peters WH, Drenth JP. Assessment of oxidative stress in chronic pancreatitis patients. World J Gastroenterol 2006;12:5705-5710.
29. Koracevic D, Koracevic G, Djordjevic V, Andrejevic S, Cosic V. Method for the measurement of antioxidant activity in human fluids. J Clin Pathol 2001;54:356-361.
30. Andriollo-Sanchez M, Hininger-Favier I, Meunier N, Venneria E, O'Connor JM, Maiani G, Coudray C, Roussel AM. Age-related oxidative stress and antioxidant parameters in middle-aged and older European subjects: The ZENITH study. Eur J Clin Nutr 2005;59(Suppl 2):S58-62.
31. Mutlu-Türkoǧlu U, Ilhan E, Oztezcan S, Kuru A, Aykac-Toker G, Uysal M. Age-related increases in plasma malondialdehyde and protein carbonyl levels and lymphocyte DNA damage in elderly subjects. Clin Biochem 2003;36:397-400.
32. Nowak M, Swietochowska E, Wielkoszyński T, Marek B, Karpe J, Górski J, Głogowska-Szelag J, Kos-Kudła B, Ostrowska Z. Changes in blood antioxidants and several lipid peroxidation products in women with age-related macular degeneration. Eur J Ophthalmol 2003;13:281-286.